Built Before. Scaled to 1,200 Centers. Doing It Again.
Founder of AnciCare (acquired by a public company) is building the infrastructure layer for diagnostic imaging — bringing a proven model to a $100B+ market serving 90 million underserved Americans.
Private investor briefings — limited availability
Founder & Track Record
Built by the Founder Who Already Solved This Once
Michael Cabrera is the founder of AnciCare PPO — the first national diagnostic imaging network focused on reducing costs and improving access.
He built the network to over 1,200 imaging centers, scaled it to $20M in annual revenue, and successfully exited to a public company.
USRad is not a new idea.
It is the evolution of that model — rebuilt with modern infrastructure to scale nationally and serve a significantly larger market.
USRad transforms a traditional network into an infrastructure layer — one that actively directs patient demand based on performance, not relationships.
"I've seen firsthand how broken the imaging market is — and how powerful it becomes when you fix it.
USRad is the next version of that system, built to scale nationally."
— Michael Cabrera, Founder & CEO
Proven Track Record
Why This Matters
- · First national imaging network built and scaled from zero
- · Deep provider relationships across major markets
- · Proven ability to execute, grow, and exit
- · Rebuilding the model with modern infrastructure at 10× scale
The Market Is Massive. And Overlooked.
Traditional healthcare has failed 90 million Americans. We're building the solution.
90M+
Underserved Americans
Uninsured and underinsured patients forced to delay or skip necessary imaging
$100B+
Annual Market Spend
Medical imaging market with massive inefficiencies and price opacity
30-80%
Cost Savings
Typical patient savings versus hospital pricing through our network
How USRad Creates Value
Four structural advantages that compound with scale
Supply Aggregation at Scale
ACR-accredited facilities recruited and credentialed into a proprietary network — supply that competitors cannot quickly replicate
Price Compression Engine
Flat-rate upfront pricing drives systematic cost reduction across markets — creating a price benchmark competitors are measured against
Quality Standardization Layer
Subspecialized board-certified radiologists across all network centers establish a quality floor that protects the platform's reliability signal
Automated Demand Routing
Patient demand is systematically matched and routed to network providers — creating a scalable allocation engine that improves with volume
Capital-Efficient Revenue Model
USRad collects patient payments upfront and pays providers on a 10-day cycle — creating positive working capital and capital-efficient growth from day one.
Margin earned on every imaging order placed through the platform — no insurance, no denial, no friction
Contracted imaging benefits for self-insured employer groups — high volume, predictable revenue, capital-light expansion
Proprietary pricing and performance data across 43,600+ procedure-market combinations — a platform layer competitors cannot replicate
USRad earns margin on efficiency — not denial or volume. Patient pays upfront. Provider paid on day 10. The float is structural, not incidental.
Strategic Growth Roadmap
Deliberate sequencing: Establish dominance in imaging, then expand from a position of structural advantage.
Each phase builds on the previous — increasing efficiency, strengthening network effects, and expanding the platform's economic advantage.
Phase 1: Core Domination
2025-2026
National Supply Density
Build high-density coverage across major metropolitan markets — creating a network advantage that improves matching efficiency and pricing power.
Demand Aggregation Engine
Consolidate patient demand through a unified platform — increasing volume concentration and strengthening routing precision across the network.
Market Standardization
Establish USRad pricing and fulfillment as the benchmark for self-pay imaging — shifting market expectations toward transparent, fixed-rate care.
Phase 2: Strategic Expansion
2027+
Adjacency Expansion
Extend the platform into adjacent diagnostic categories using the existing provider network and demand infrastructure — entering new markets with built-in advantage.
Care Continuum Integration
Expand from diagnostic access into coordinated care pathways — positioning USRad as the entry point into downstream healthcare services.
Multi-Payor Penetration
Expand beyond self-pay into employer-sponsored and other payor models — increasing volume, retention, and lifetime value per patient.
Core Philosophy: USRad does not expand to grow. It expands after establishing structural dominance — leveraging existing supply, demand, and pricing infrastructure to enter adjacent markets with compounding advantage.
De-Risked Business Model
Proven playbook enhanced with modern technology for rapid scaling
AnciCare Success Blueprint
Built & scaled to $20M revenue
Proven ability to execute in this market
Successful exit to public company
Demonstrated value creation for investors
Deep industry relationships
25+ years building trusted partnerships
USRad Enhancements
Modern tech stack for 10x scale
Cloud-native platform built for nationwide expansion
Capital-efficient operations
10-day provider payments maintain positive working capital
Larger addressable market
90M self-pay vs. limited workers' comp market
Positive Working Capital Model
Like AnciCare's successful float model, USRad maintains positive cash flow through strategic payment timing
Patient pays upfront
Provider payment
Cash float advantage
Why Now?
Market forces have created the perfect timing for USRad's model
Post-COVID Healthcare
Consumers now expect digital-first, transparent healthcare experiences
Price Transparency Laws
New regulations require hospitals to publish prices, exposing massive markups
Consumer-Driven Care
High-deductible plans push patients to shop for value
Tech Ready
Cloud platforms enable rapid scaling at fraction of historical costs
Ready to Learn More?
Partner with a proven team building infrastructure that lasts.
Private investor briefings — limited availability
For qualified investors only. Materials are confidential and not for redistribution.